November 2021 - Page 23 of 29

FridayNov 05, 2021 9:00 am

FuelPositive Corp. (TSX.V: NHHH) (OTCQB: NHHHF) CEO Discusses Importance of Company’s New Additions to the Management Team

September 2021 saw four new additions to FuelPositive’s management team Each of the new appointments brings with them decades of experience, technical know-how and strategic approaches that will guide the company’s future decisions and investments Ian Clifford, FuelPositive’s CEO and chair, has acknowledged that some of these appointments have come at “just the right time” Ian Clifford, the chief executive officer and chair of the board at FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF), while appearing in an interview on the company’s YouTube channel, expressed his optimism and enthusiasm about four new appointments the company made over the month of September. “It’s just a great day for us to add to our…

ThursdayNov 04, 2021 3:14 pm

QualityStocksNewsBreaks – Save Foods Inc. (NASDAQ: SVFD) to Pursue Larger Scale Research Collaboration with UC Riverside

Save Foods (NASDAQ: SVFD), an agrifood tech company focused on developing and selling eco-friendly products specifically designed to extend the shelf life and ensure the safety of fresh fruits and vegetables, today announced increased collaboration with the University of California, Riverside (“UC Riverside”). The move follows the completion of several successful field trials of Save Foods’ pre-harvest products conducted by Dr. Jim Adaskaveg, UC Riverside’s professor at the microbiology and plant pathology department. SVFD’s board of directors subsequently approved increased collaboration with the university and instructed the company’s scientific team to present a working plan for the pre-harvest application within…

ThursdayNov 04, 2021 3:00 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc.’s (PBIO) BaroFold Platform Brings Key Capabilities Amid Strong Demand for Protein Therapeutics

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of broadly enabling, high pressure-based instruments, platform technologies and related consumables for the worldwide life sciences, agriculture, food and beverage, and other key industries, today announced the strategic expansion of its patented BaroFold technology platform, with continued growth in services, sales and leasing. According to the update, proteins have become the biological molecule of choice in therapeutic drug development due to their high degree of specificity, proven efficacy and minimal side effects. The global protein therapeutics market is expected to reach US $233 billion by 2027. However, the…

ThursdayNov 04, 2021 2:25 pm

QualityStocksNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Announces Q3 2021 Financial Results Conference Call

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS (“SaaS”) platform, will be hosting a conference call on Nov. 15, 2021; the call will be discussing the company’s third quarter 2021 financial report. According to the announcement, SRAX founder and CEO Christopher Miglino and CFO Michael Malone will facilitate the webcast as well as offer an operational and financial summary of third-quarter results. The video call will also include time for questions and answer. The live webcast and presentation is scheduled to begin at 4:30 p.m. ET. Those interested…

ThursdayNov 04, 2021 2:10 pm

QualityStocksNewsBreaks – InnerScope Hearing Technologies Inc. (INND) Deploys Hearing Kiosks in Hartig Drug Locations, Plans Additional Partnership Efforts

InnerScope Hearing Technologies (OTC: INND), an emerging and disruptive leader in the direct-to-consumer hearing technology space, is partnering with Hartig Drug Company to offer free hearing screenings through INND’s automated self-check hearing screening kiosks. According to the announcement, Innerscope hearing screening kiosks have been made available in three of Hartig Drug locations: Dubuque, Iowa; Galena, Illinois; and Platteville, Wisconsin. Hartig is a member of Topco Associates, a member-owned cooperative. The two companies anticipate deploying additional hearing kiosks in other Hartig Drug locations. The company noted that Hartig Drug would also be offering InnerScope’s direct-to-consumer hearing aids as well as other hearing…

ThursdayNov 04, 2021 1:57 pm

QualityStocksNewsBreaks – Playgon Games Inc. (TSX.V: DEAL) (OTCQB: PLGNF) (FRA:7CR) Issues Clarification on Upsizing of Previously Announced Private Placement

Playgon Games (TSX.V: DEAL) (OTCQB: PLGNF) (FRA:7CR), a propriety software-as-a-service (“SaaS”) technology company delivering mobile live dealer technology to online gaming operators globally, has announced that, further to its Oct. 28 and Nov. 3 news releases, it intends to upsize its previously announced non-brokered private placement (the “proposed offering”) of units of the company. According to the update, the upsized proposed offering is expected to be for gross proceeds of up to $9,000,000 through the sale of up to 30,000,000 units, each at a price of $0.30. Each unit will be comprised of one common share of the company and…

ThursdayNov 04, 2021 1:44 pm

QualityStocksNewsBreaks – Net Element Inc. (NASDAQ: NETE) Releases Update on Post-Merger Share Count

Net Element (NASDAQ: NETE), a global technology and value-added solutions group, and Mullen Automotive Inc., an emerging electric vehicle (“EV”) manufacturer, has shared updated information regarding a previously announced definitive stock-for-stock reverse merger agreement between the two companies. In the announcement, Mullen noted that the number of fully diluted shares upon completion of the merger will be 32% less than the 75 million shares outlined in the agreement. Following the merger, the number of outstanding shares will be 51,173,640 million in total. “We are excited about the many milestones ahead of us and look forward to sharing those with all our…

ThursdayNov 04, 2021 1:22 pm

QualityStocksNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH), Provides Studies, Clinical Trials Update

Mind Cure Health (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH), a leader in advanced proprietary technology and research for psychedelics, has released an update on strategic initiatives related to its MINDCURE Research and MINDCURE Technology divisions. According to the company, its synthetic ibogaine efforts, which were announced in March 2021, include the application for two patents and the initiation of production of Good Laboratory Practice (“GLP”) ibogaine leading to the production of Good Manufacturing Practice (“GMP”) ibogaine. The company is on schedule to provide GLP supply to research partners by Q2 2022. The company is in the process of preparing to ship…

ThursdayNov 04, 2021 1:00 pm

Playgon Games Inc. (TSX.V: DEAL) (OTCQB: PLGNF) Experiencing Massive Growth Ahead of American Gaming Association’s Bullish 2022 Prediction

American Gaming Association’s Gaming CEO Outlook expects industry growth in 2020 driven by new hiring, wage growth, and capital investment PLGNF sees explosive growth in October 2021 with a 1500% betting handle increase, and betting turnover reached approximately $1.6 million per day from $53,500 for September PLGNF’s IP-protected iGaming software solutions include Live Dealer Casino, E-Table Games, Daily Fantasy Sports PLGNF applications run securely on any browser without app store download, do not require sharing sensitive data Playgon Games (TSX.V: DEAL) (OTCQB: PLGNF), a SaaS technology company focused on developing and licensing digital content for the growing global iGaming market,…

ThursdayNov 04, 2021 12:47 pm

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Marks Another Significant Milestone with IND Application for Fibromyalgia Phase 2a Clinical Trial

Tryp just filed an IND with the FDA for its TRP-8802 clinical candidate for its Phase 2a clinical trial The trial is set to commence in 2022, subject to a favorable review by the FDA The study will be conducted in collaboration with the University of Michigan and will aim at evaluating the safety and clinical utility of psilocybin for fibromyalgia Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) just announced its submission of an Investigational New Drug (“IND”) application to the United States Food and Drug Administration (“FDA”) for its TRP-88802 clinical candidate. This application follows the commencement of Tryp’s Phase…

Site Search

Company Search

Month: November 2021